OR WAIT null SECS
© 2023 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
VP, Managed Care Marketing, Merck
DOUBLE DUTY: Is helping build Merck's new healthcare model
OF NOTE: First non-finance person to run Merck's investor relations
For many years, the success of the industry was at least in part driven by the inefficiency of the economic model of healthcare. In the short term, there's always more to be eked out from the current model—and I think some companies are going to run with that as hard and as long as they can. But in the long term, companies have to understand that the market is going to be increasingly influenced by the people who pay the bills—payers and consumers. In that way, pharma will start to become more like most other industries.